REQUEST A DEMO
Total
USD $0.00
Search more companies

Szent Istvan Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: SZENT ISTVAN PHARMA Gyogyszereszeti Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Szent Istvan Pharma Bt. is based in Hungary. The head office is in Esztergom. It operates in the Pharmacies and Drug Stores sector. Szent Istvan Pharma Bt. was incorporated on July 05, 1996. 7 (2024) employees currently work for Szent Istvan Pharma Bt.. In 2023, the company reported a net sales revenue increase of 12.5%. Its’ total assets recorded a growth of 12.77%. Szent Istvan Pharma Bt.’s net profit margin increased by 0.66% in 2023.

Headquarters
Szechenyi ter 24-26.
Esztergom; Komarom-Esztergom; Postal Code: 2500

Contact Details: Purchase the Szent Istvan Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Szent Istvan Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Szent Istvan Pharma Bt. report to view the information.
Registered Capital:
Purchase the Szent Istvan Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Szent Istvan Pharma Bt. report to view the information.
Incorporation Date:
July 05, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Szent Istvan Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.5%
Total operating revenue
12.33%
Operating profit (EBIT)
30.9%
EBITDA
29.14%
Net Profit (Loss) for the Period
23.36%
Total assets
12.77%
Total equity
34.23%
Operating Profit Margin (ROS)
1.22%
Net Profit Margin
0.66%
Return on Equity (ROE)
-7.76%
Quick Ratio
0.36%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?